| Literature DB >> 30217722 |
A Serrano Russi1, S Donoghue2, A Boneh3, R Manara4, A B Burlina5, A P Burlina6.
Abstract
Three young patients with glutaric aciduria type I (age 6-23 years) of different ethnic origins, treated for their metabolic disease since early childhood, presented with malignant central nervous system tumors. We recommend continuing clinical follow-up, including monitoring of neurological manifestations and neuroradiological findings, in all patients with glutaric aciduria type I beyond early childhood, especially if adherence to diet is poor or the treatment was not started neonatally.Entities:
Mesh：
Substances：
Year: 2018 PMID： 30217722 DOI： 10.1016/j.ymgme.2018.08.006
Source DB: PubMed Journal: Mol Genet Metab ISSN： 1096-7192 Impact factor: 4.797